How to buy GW Pharmaceuticals shares?

With the legalization of weed in large parts of North America, it has become a real growth market. GW Pharmaceuticals is one of the companies that benefit from this. With cannabidiol, they treat, among other things, tuberous sclerosis-related attacks. Do you want to invest in this promising company? Then quickly find out how to buy shares in GW Pharmaceuticals or take a look at the current price!

Where can you buy GW Pharmaceuticals stocks?

Do you want to buy GW Pharmaceuticals shares? You can directly trade in GW Pharmaceuticals stocks with one of these reliable brokers:

eToro buy stocksBuy GW Pharmaceuticals without commissions. Your capital is at risk. Other fees may apply.
Plus500 trade stocksSpeculate with CFD's on increasing & decreasing prices of GW Pharmaceuticals! 82% of retail CFD accounts lose money.
DEGIRO buy sharesBenefit from low fees, an innovative platform & high security!
Avatrade buy sharesSpeculate on price increases and decreases of GW Pharmaceuticals with a free demo!

How can you actively invest in GW Pharmaceuticals?

Shares with a lot of volatility can be interesting for active investors. This way you can take all the short trips up and down. The GW Pharmaceuticals share has strong movements and is therefore very suitable for active trading.

Are you looking for a party where you can actively trade in GW Pharmaceuticals? Then Plus500 is a good option! You can try the possibilities at Plus500 with a free demo. Use the button below to start trading with Plus500 right away:

82% of retail CFD accounts lose money.82% of retail CFD accounts lose money.82% of retail CFD accounts lose money.

What is the current stock price of GW Pharmaceuticals?

Would you like to know what the stock price of GW Pharmaceuticals is like? Then take a look at the current price of the CFD share of GW Pharmaceuticals below. You can also use the buttons to directly place a new order.

More about GW Pharmaceuticals

GW Pharmaceuticals is a biopharmaceutical company active in the field of innovation, development, and commercialization of medicines. These are new medicines that are not yet on the market.

Their main product is a cannabinoid product under the name cannabidiol (CBD) and helps in the treatment of seizures related to tuberous sclerosis complex. GW Pharmaceuticals Plc was founded in 1998. Brian Whittle and Geoffrey William Guy are the founders.

The company is headquartered in the United Kingdom. They are the world leader in innovation for cannabinoid-based medicines. The company’s drugs work alongside the treatment of multiple sclerosis in some forms of epilepsy in children.

Investing in GW Pharmaceuticals

The history of GW Pharmaceuticals

The company was founded in 1998 and immediately received a cultivation licence to grow cannabis legally. This allowed them to immediately start research for the medicinal use of the plant. A year later the company started working together with HortaPharm bv.

GW Pharmaceuticals is a cannabis research and development company in Amsterdam. The company is allowed by the Dutch government to develop specialized cannabis strains. In 2001 GW Pharmaceuticals was listed on the AIM which is a junior market on the London Stock Exchange. In 2013 GW Pharmaceuticals was also listed on Nasdaq. It is, therefore, possible to buy shares of this company.

The products of GW Pharmaceuticals

The most important product at the moment is Sativex: a cannabis extract that is administered via a mouth spray. The drug was approved in 2010 and helps people with multiple sclerosis (MS). The drug helps to fight the pain. Also, the drug helps to improve spasticity and to relieve the bladder. In 2011, they set up a partnership with Bayer to distribute the drug. Annually they now make 100 tons of medicinal cannabis.

Developing new products

GW Pharmaceuticals is also actively developing new products. Epidiolex is a good example of this: it was launched on the market in 2019 and was an instant hit.

This new drug can be a great success and can be a good reason to buy shares of this company. GW Pharmaceuticals is very pleased with the launch of the drug which can make a big difference for its patients.

Marijuana, a new growth market?

The cannabis market is a clear growth market in North America and can increase tens of percent annually. The entire global market could grow to 340 billion.

This growth is due to the legalization of medical and private use. If you want to make a financial success of this, you have to invest in the right companies. GW Pharmaceuticals has been mentioned as a good candidate for strong growth thanks to developments.

In the case of GW Pharmaceuticals, however, it is important to be vigilant. The company is still very dependent on one specific drug. Therefore, keep a close eye on the competition before investing in GW Pharmaceuticals!


Alex Mostert Avatar

When I was 16, I secretly bought my first stock. Since that ‘proud moment’ I have been managing for over 10 years. It is my goal to educate people about financial freedom. After my studies business administration and psychology, I decided to put all my time in developing this website. Since I love to travel, I work from all over the world. Click here to read more about! Don’t hesitate to leave a comment under this article.

Leave a Reply

Your email address will not be published. Required fields are marked *